Performance evaluation and characterization of pre-analytical effects by sample types and storage conditions on tumor marker measurement by the point-of-care test platform IchromaTM II

被引:1
作者
Lee, Sojin [1 ]
Jang, Jaehyeok [1 ]
Jang, Hanmil [1 ]
Kang, Hyein [1 ,2 ]
Rim, John Hoon [1 ]
Lim, Jong-Baeck [1 ]
机构
[1] Yonsei Univ, Severance Hosp, Dept Lab Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Keimyung Univ, Sch Med, Dept Lab Med, 1035 Dalgubeol Daero, Daegu 42601, South Korea
关键词
Point-of-care test; Pre-analytical factor; Tumor marker; Stability; Biospecimen; WHOLE-BLOOD; STABILITY; SERUM; BIOMARKERS; PSA;
D O I
10.1016/j.cca.2024.119902
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Tumor markers should be measured regularly and accurately to prevent, diagnose, and monitor cancers efficiently. We aimed to characterize the pre-analytical factors effecting on the analytical performance of point-ofcare test (POCT) platform IchromaTM II (Boditech Med Inc., Gangwon-do, Korea) for alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), and prostate specific antigen (PSA) and evaluate their consequences in clinical practice. Based on comprehensive evaluation for the analytical performance of IchromaTM II including precision, linearity, and method comparison performed according to CLSI guidelines, pre-analytical factors of sample types and conditions were extensively analyzed. A total of five sample types [serum, plasma (PL) and whole blood (WB) from EDTA tube, PL and WB from sodium heparin tube] from 40 patients were used for comparing among specimen types. Additionally, stability was assessed up to 21 h at room temperature, refrigerated for 8 days, and frozen for 16 weeks by using 4 levels of pooled patient samples which were measured in triplicate. Precision, linearity and correlation with central laboratory analyzers observed in all three tumor markers were within acceptable criteria. However, variable degrees of percent deviations were observed according to sample type and storage conditions. Only EDTA PL samples presented clinically acceptable percentage biases for all three tumor markers when stored at room temperature or refrigerated condition. Positive bias of CEA and PSA in storage duration until 16 weeks were observed when stored in frozen condition. While IchromaTM II showed an adequate analytical performance as a POCT platform with simple operating procedures for the measurement of tumor markers, clinical laboratories should be aware of stability issues when different types of blood specimens are practically utilized.
引用
收藏
页数:7
相关论文
共 16 条
  • [1] Should AFP (or Any Biomarkers) Be Used for HCC Surveillance?
    Hager F. Ahmed Mohammed
    Lewis R. Roberts
    [J]. Current Hepatology Reports, 2017, 16 (2) : 137 - 145
  • [2] Pre-clinical validation study of a miniaturized electrochemical immunoassay based on square wave voltammetry for early detection of carcinoembryonic antigen in human serum
    Dolores Martinez-Mancera, Flavio
    Garcia-Lopez, Patricia
    Luis Hernandez-Lopez, Jose
    [J]. CLINICA CHIMICA ACTA, 2015, 444 : 199 - 205
  • [3] Biomarker Detection in Early Diagnosis of Cancer: Recent Achievements in Point-of-Care Devices Based on Paper Microfluidics
    Erkocyigit, Bilge Asci
    Ozufuklar, Ozge
    Yardim, Aysenur
    Celik, Emine Guler
    Timur, Suna
    [J]. BIOSENSORS-BASEL, 2023, 13 (03):
  • [4] Stability and accuracy of total and free PSA values in samples stored at room temperature
    Forde, J. C.
    Blake, O.
    Crowley, V. E.
    Lynch, T. H.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 (04) : 989 - 991
  • [5] Stability of [-2] Pro-PSA in Whole Blood and Serum: Analysis for Optimal Measurement Conditions
    Igawa, Tsukasa
    Takehara, Kosuke
    Onita, Toru
    Ito, Kazuto
    Sakai, Hideki
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2014, 28 (04) : 315 - 319
  • [6] Jin J, 2017, AM J CANCER RES, V7, P1384
  • [7] Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE)
    Lippi, Giuseppe
    Banfi, Giuseppe
    Church, Stephen
    Cornes, Michael
    De Carli, Gabriella
    Grankvist, Kjell
    Kristensen, Gunn B.
    Ibarz, Mercedes
    Panteghini, Mauro
    Plebani, Mario
    Nybo, Mads
    Smellie, Stuart
    Zaninotto, Martina
    Simundic, Ana-Maria
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (03) : 357 - 370
  • [8] Biomarkers in cancer staging, prognosis and treatment selection
    Ludwig, JA
    Weinstein, JN
    [J]. NATURE REVIEWS CANCER, 2005, 5 (11) : 845 - 856
  • [9] Serum or plasma? An old question looking for new answers
    Plebani, Mario
    Banfi, Giuseppe
    Bernardini, Sergio
    Bondanini, Francesco
    Conti, Laura
    Dorizzi, Romolo
    Ferrara, Fulvio Enrico
    Mancini, Rita
    Trenti, Tommaso
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (02) : 178 - 187
  • [10] Development of electrochemical biosensors for tumor marker determination towards cancer diagnosis: Recent progress
    Sadighbayan, Deniz
    Sadighbayan, Khosrow
    Tohid-Kia, Mohammad Reza
    Khosroushahi, Ahmad Yari
    Hasanzadeh, Mohammad
    [J]. TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2019, 118 : 73 - 88